FDA-Drug2026-08-19Class IIPROCESSING DEFECT

Apollo Care semaglutide injection recalled for particulate matter contamination

PLASTICNationwide distributionDrugs

What this means

Apollo Care semaglutide 6.75 mg injection vials contain particulate matter (nylon/polyamide and silk-type material) that should not be present in the medication. The contamination was identified in multiple lot numbers distributed nationwide. No injuries have been reported.

  • Check your semaglutide vial against the recalled lot numbers: C-017115, AC-017163, AC-017169, AC-017170, AC-017171, AC-017230, and AC-017231.
  • Do not use vials from the affected lots.
  • Contact your pharmacist or prescriber for a replacement vial or alternative medication.
  • If you have already injected from a recalled vial and have concerns, contact your doctor.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the U.S
Affected count
37,546 vials.
Manufactured in
3801 Mojave Ct Ste 101, Columbia, MO, United States
Products
SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-821-01

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0749-2026

More Apollo Care recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.